According to a commentary, a virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States. The commentary was by two Mayo Clinic physicians in the October issue of the journal iMayo Clinic Proceedings/i. Value-based pricing is one potential solution, they write. VIDEO ALERT: Video of Dr. Rajkumar discussing the commentary is posted on the Mayo Clinic ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment